These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7871119)

  • 1. Structural and functional correlates of subsyndromes in chronic schizophrenia.
    Schröder J; Buchsbaum MS; Siegel BV; Geider FJ; Niethammer R
    Psychopathology; 1995; 28(1):38-45. PubMed ID: 7871119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Subsyndromes in chronic schizophrenia. The heterogeniety of schizophrenic psychoses].
    Schröder J
    Fortschr Neurol Psychiatr; 1998 Jan; 66(1):15-31. PubMed ID: 9530553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subsyndromes in chronic schizophrenia: do their psychopathological characteristics correspond to cerebral alterations?
    Schröder J; Geider FJ; Binkert M; Reitz C; Jauss M; Sauer H
    Psychiatry Res; 1992 Jun; 42(3):209-20. PubMed ID: 1496053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia.
    Schroder J; Buchsbaum MS; Siegel BV; Geider FJ; Lohr J; Tang C; Wu J; Potkin SG
    Schizophr Res; 1996 Mar; 19(1):41-53. PubMed ID: 9147495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memory deficits in subsyndromes of chronic schizophrenia.
    Schröder J; Tittel A; Stockert A; Karr M
    Schizophr Res; 1996 Jul; 21(1):19-26. PubMed ID: 8998272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of cortical activity in schizophrenia.
    Schroeder J; Buchsbaum MS; Siegel BV; Geider FJ; Haier RJ; Lohr J; Wu J; Potkin SG
    Psychol Med; 1994 Nov; 24(4):947-55. PubMed ID: 7892362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct pattern of brain structural deficits in subsyndromes of schizophrenia delineated by psychopathology.
    Nenadic I; Sauer H; Gaser C
    Neuroimage; 2010 Jan; 49(2):1153-60. PubMed ID: 19833216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype progression and pathophysiologic deterioration in early schizophrenia.
    McGlashan TH; Fenton WS
    Schizophr Bull; 1993; 19(1):71-84. PubMed ID: 8451614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The failure of the schizophrenia concept and the argument for its replacement by hebephrenia: applying the medical model for disease recognition.
    Taylor MA; Shorter E; Vaidya NA; Fink M
    Acta Psychiatr Scand; 2010 Sep; 122(3):173-83. PubMed ID: 20649527
    [No Abstract]   [Full Text] [Related]  

  • 11. Negative symptoms and hypofrontality in chronic schizophrenia.
    Wolkin A; Sanfilipo M; Wolf AP; Angrist B; Brodie JD; Rotrosen J
    Arch Gen Psychiatry; 1992 Dec; 49(12):959-65. PubMed ID: 1360200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients.
    Cleghorn JM; Szechtman H; Garnett ES; Nahmias C; Brown GM; Kaplan RD; Szechtman B; Franco S
    Psychiatry Res; 1991 Oct; 40(2):135-53. PubMed ID: 1763143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia.
    Cuesta MJ; Peralta V
    Psychiatry Res; 1995 Oct; 58(3):227-35. PubMed ID: 8570778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom structure in schizophrenia: two-, three- or four-factor models?
    Dollfus S; Everitt B
    Psychopathology; 1998; 31(3):120-30. PubMed ID: 9636941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional neuroanatomy of schizophrenic subsyndromes.
    Honey GD; Sharma T; Suckling J; Giampietro V; Soni W; Williams SC; Bullmore ET
    Psychol Med; 2003 Aug; 33(6):1007-18. PubMed ID: 12946085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The left medial temporal region and schizophrenia. A PET study.
    Friston KJ; Liddle PF; Frith CD; Hirsch SR; Frackowiak RS
    Brain; 1992 Apr; 115 ( Pt 2)():367-82. PubMed ID: 1606474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates.
    Wiesel FA; Wik G; Sjögren I; Blomqvist G; Greitz T; Stone-Elander S
    Acta Psychiatr Scand; 1987 Dec; 76(6):628-41. PubMed ID: 3502060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The P 300 potential in schizophrenia].
    Laurent A; Garcia-Larrea L; Dalery J; Terra JL; D'Amato T; Marie-Cardine M; Mauguière F
    Encephale; 1993; 19(3):221-7. PubMed ID: 8275907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia.
    O'Leary DS; Flaum M; Kesler ML; Flashman LA; Arndt S; Andreasen NC
    J Neuropsychiatry Clin Neurosci; 2000; 12(1):4-15. PubMed ID: 10678506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.